Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
xsome Therapeutics initiates phase 2/3 trial of AXS-05 for Alzheimer's disease agitation
Axsome Therapeutics has enrolled the first patient in the ADVANCE-1 (Addressing Dementia Via Agitation-Centered Evaluation 1) study, a Phase 2/3 trial evaluating efficacy and safety of AXS-05 for treatment of Alzheimer’s disease agitation.
July 17, 2017
More...
Email This Page
to a Friend
Print This
Page